Screening of human vascular endothelial growth factor (VEGF) receptor Flt-1 domain and study on its biological activity

被引:0
|
作者
马骊
张智清
王小宁
孙大军
周小明
陈爱君
姚立红
机构
关键词
vascular endothelial growth factor (VEGF); receptor; yeast two-hybrid; Pichia; pastoris; gene expression;
D O I
暂无
中图分类号
Q523 [脱氧核糖核酸(DNA)];
学科分类号
摘要
Four human vascular endothelial growth factor receptor Flt-1 cDNA fragments containing extracellular domain loops 2, 1-2, 2-3 and 1-3 respectively were amplified from human placen-tal cDNA library by PCR and used for screening ligand binding domains by yeast two-hybrid system. The result showed that, not only loop 1-3, but also the smaller fragment loop 2-3 could bind to hVEGF165. Recombinant expression plasmids pPIC9K/Flt-1(1-3) and pPIC9K/Flt-1 (2-3) were constructed and transformed to Pichia. pastoris host strain GS115, cultured in flasks, and expressed under the induction of 1 % methanol. The expressed product existed in supernatant in the form of soluble molecules and contained more than 60% of total protein after being induced for 4d. After being purified by CM-Sepharose FF and Sephacryl S-100 chromatography, its purity reached above 90%. Biological assay in vitro showed that the binding capacity of expressed soluble Flt-1 (2-3) to hVEGF165 and its inhibiting effect on the proliferation of human um
引用
收藏
页码:497 / 505
页数:9
相关论文
共 50 条
  • [21] Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase)
    Tanaka, K
    Yamaguchi, S
    Sawano, A
    Shibuya, M
    JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (09): : 867 - 876
  • [22] Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells
    Barleon, B
    Siemeister, G
    MartinyBaron, G
    Weindel, K
    Herzog, C
    Marme, D
    CANCER RESEARCH, 1997, 57 (23) : 5421 - 5425
  • [23] Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR
    Chintalgattu, V
    Nair, DM
    Katwa, LC
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2003, 35 (03) : 277 - 286
  • [24] Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves disease possibly correlated with increased vascular density
    Nagura, S
    Katoh, R
    Miyagi, E
    Shibuya, M
    Kawaoi, A
    HUMAN PATHOLOGY, 2001, 32 (01) : 10 - 17
  • [25] Expression of human vascular endothelial growth factor receptor Flt-1 extracellular domain 1-3 loop cDNA in Pichia pastoris, purification of the expressed product and detection of its biological activity
    Ma, L
    Wang, XN
    Zhang, ZQ
    Zhou, XM
    Zeng, GF
    Chen, AJ
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2001, 14 (04) : 292 - 301
  • [27] Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1
    Barleon, B
    Totzke, F
    Herzog, C
    Blanke, S
    Kremmer, E
    Siemeister, G
    Marme, D
    MartinyBaron, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (16) : 10382 - 10388
  • [28] Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1
    Takeda, N
    Maemura, K
    Imai, Y
    Harada, T
    Kawanami, D
    Nojiri, T
    Manabe, I
    Nagai, R
    CIRCULATION RESEARCH, 2004, 95 (02) : 146 - 153
  • [29] Detection of vascular endothelial growth factor (VEGF) and VEGF receptors Flt-1 and KDR in canine mastocytoma cells
    Rebuzzi, Laura
    Willmann, Michael
    Sonneck, Karoline
    Gleixner, Karoline V.
    Florian, Stefan
    Kondo, Rudin
    Mayerhofer, Matthias
    Vales, Anja
    Gruze, Alexander
    Pickl, Winfried F.
    Thalhammer, Johann G.
    Valent, Peter
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2007, 115 (3-4) : 320 - 333
  • [30] Flt-1, a receptor for vascular endothelial growth factor, has transforming and morphogenic potentials
    Yoshiro Maru
    Sachiko Yamaguchi
    Masabumi Shibuya
    Oncogene, 1998, 16 : 2585 - 2595